We look forward to welcoming you to the LI-COR virtual sessions where you will have the opportunity to learn about robust Western blotting tecniques and targeted therapeutic development tools.
Join us to the last on-line sessions on 18th June!
June 18, 11:00h.
«Assays and Solutions for Targeted Therapeutic Development»
Dr. Shula DawsonSolutions Support Scientist Team LeaderLI-COR
«In-cell western assay: application in drug development for Duchenne muscular dystrophy»
Patricia Soblechero, Reasercher at Biocruces Bizkaia Instituto Investigación Sanitaria
Want to do personalized medicine? Try Do targeted proteomics!»
Dr. Christian Regenbrecht
CEO ASC Oncology, CEO CELLphenomics..
Save the date!